Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Pfizer Alum's Banks $45 Million Series C May 22, 2017 Emergent BioSolutions Unveils Its Expanded Center For Innovation In Advanced Development And Manufacturing In Baltimore May 9, 2017 Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.' November 28, 2017
Emergent BioSolutions Unveils Its Expanded Center For Innovation In Advanced Development And Manufacturing In Baltimore May 9, 2017